Pharmaceutical products list

Levosimendan is used in a range of conditions requiring inotropic support, including right ventricular failure, cardiogenic shock, septic shock, and Takotsubo cardiomyopathy

It enhances myocardial contractility without increasing oxygen requirements, and causes coronary and systemic vasodilation

Carfilzomib is approved for the treatment of multiple myleoma, a plasma cell cancer, often in combination with other medicines with a similar therapeutic effect

It is used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous treatments

Teriflunomide is an immunomodulatory drug indicated for the treatment of multiple sclerosis. Teriflunomide provides a therapeutic benefit, and importantly, does not cause clinical immune suppression

Developed initially to treat obesity, Fenfluramine is currently undergoing Phase III clinical trials as an anticonvulsant agent to treat refractory generalized tonic-clonic seizures in Dravet syndrome